Human Immunology News Volume 8.44 | Nov 10 2020

    0
    63








    HIN 8.44 | Nov 10 2020


    Human Immunology News by STEMCELL Technologies
    Vol. 8.44 – 10 November, 2020
    TOP STORY

    Inhibition of LTβR Signaling Activates WNT-Induced Regeneration in Lung

    Scientists demonstrated increased expression of lymphotoxin β-receptor (LTβR) ligands in adaptive and innate immune cells, enhanced non-canonical NF-κB signaling, and enriched LTβR target gene expression in lung epithelial cells from patients with smoking-associated chronic obstructive pulmonary disease.
    [Nature]

    Full Article

    Start Fast. Finish Faster. Streamline your assays with purified human primary cells from STEMCELL Technologies. View products now.
    PUBLICATIONSRanked by the impact factor of the journal

    NAD+
    Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion

    Investigators found nicotinamide phosphoribosyltransferase, the rate-limiting enzyme of the NAD+ biogenesis, drove interferon γ-induced PD-L1 expression in multiple types of tumors and governed tumor immune evasion in a CD8+ T cell-dependent manner.
    [Cell Metabolism]

    AbstractGraphical Abstract

    Antibody
    Binding to Native Cytomegalovirus Glycoprotein B Predicts Efficacy of the GB/MF59 Vaccine in Humans

    Scientists investigated the humoral immune correlates of protection from cytomegalovirus (CMV) acquisition in populations of CMV-seronegative adolescent and postpartum women who received the gB/MF59 vaccine.
    [Science Translational Medicine]

    Abstract

    Co-Administered
    Antibody Improves Penetration of Antibody–Dye Conjugate into Human Cancers with Implications for Antibody–Drug Conjugates

    Researchers report a retrospective exploratory analysis of the trial to evaluate whether co-administration of an unconjugated antibody could improve the intratumoral distribution of the antibody-dye conjugate in patients.
    [Nature Communications]

    Full Article

    Oncolytic
    Reovirus (Pelareorep) Induces Autophagy in KRAS-Mutated Colorectal Cancer

    The authors explored the effects of pelareorep on autophagy in multiple models of colorectal cancer, including patient derived PBMC.
    [Clinical Cancer Research]

    Abstract

    Novel
    Tau Biomarkers Phosphorylated at T181, T217 or T231 Rise in the Initial Stages of the Preclinical Alzheimer’s Continuum When Only Subtle Changes in Aβ Pathology Are Detected

    Investigators measured three novel cerebrospinal fluid p‐tau biomarkers, phosphorylated at threonine‐181 and threonine‐217 with an N‐terminal partner antibody and at threonine‐231 with a mid‐region partner antibody.
    [EMBO Molecular Medicine]

    Full Article

    Single-Cell
    RNA Sequencing Reveals Heterogeneous Tumor and Immune Cell Populations in Early-Stage Lung Adenocarcinomas Harboring EGFR Mutations

    Researchers identified diverse cell types within the tumor microenvironment in which myeloid cells and T cells were the most abundant stromal cell types in tumors and adjacent lung tissues.
    [Oncogene]

    Full Article

    Regulatory
    (FoxP3+) T Cells and TGF-β Predict the Response to Anti-PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer

    Scientists investigated the potential correlation between clinical outcomes and peripheral blood immune cell profiles, specifically focused on FoxP3+ Treg cells, collected at baseline and one week after anti-PD-1 therapy in two independent cohorts of patients with NSCLC.
    [Scientific Reports]

    Full Article

    Novel
    Genetic Risk Factors Influence Progression of Islet Autoimmunity to Type 1 Diabetes

    Researchers provided evidence that genetic pathways involved in progression from islet autoimmunity differ from those pathways identified once disease has been established.
    [Scientific Reports]

    Full Article

    Tools and products for your COVID-19 research.
    REVIEWS

    Glucocorticoids in T Cell Development, Differentiation and Function

    Our understanding of glucocorticoid (GC) effects on immunity comes largely from administration of exogenous GCs to treat immune or inflammatory disorders. However, it is increasingly clear that endogenous GCs both promote and suppress T cell immunity.
    [Nature Reviews Immunology]

    Abstract

    Crossing
    Boundaries: Interplay between the Immune System and Oligodendrocyte Lineage Cells

    The alternative functionality of oligodendroglia not only regulates immune cell responses, but also hinders remyelination, and might thereby be key to understanding MS disease pathology and promoting regeneration after immune-mediated demyelination.
    [Seminars in Cell & Developmental Biology]

    Full Article

    INDUSTRY AND POLICY NEWS

    XNK
    Therapeutics Receives US Orphan Drug Status for NK Cell-Based Immunotherapy in Multiple Myeloma

    XNK Therapeutics AB announced it has received Orphan Drug Designation from the FDA for its leading investigational drug candidate in the treatment of multiple myeloma.
    [XNK Therapeutics AB]

    Press Release

    Intellia
    Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyretin Amyloidosis

    Intellia Therapeutics, Inc. announced that the first patient has been treated with NTLA-2001, which the company is developing as a single-course, potentially curative therapy for transthyretin amyloidosis.
    [Intellia Therapeutics, Inc.]

    Press Release

    FEATURED EVENT

    The American Association for Cancer Research (AACR) Annual Meeting 2021

    April 9 – April 14, 2021
    Washington, DC, United States


    > See All Events

    JOB OPPORTUNITIES

    Tier 2 Canada Research Chair – Immunology and Inflammation

    Queen’s University – Kingston, Ontario, Canada


    Research Group Leader – Immunology and Infection

    MRC Laboratory of Molecular Biology – Cambridge, England, United Kingdom

    Senior
    Scientific Researcher – Immunology Discovery

    Genentech, Inc. – South San Francisco, California, United States

    PhD Student – Adoptive T Cell Therapy of Cancer

    LMU University Hospital Munich – Munich, Germany

    Postdoctoral Fellow – Cancer Immunology and Immunotherapy

    H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Human Immunology News
    Archives Contact Us
    Human Immunology News Twitter